MEDP | Medpace Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	354.99 - 367.23
52 Week Range	227.21 - 459.77
Beta	1.31
Implied Volatility	38.98%
IV Rank	42.83%
Day's Volume	239,285
Average Volume	287,393
Shares Outstanding	31,001,800
Market Cap	11,200,640,322
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	2016-08-11

Valuation
Profitability
Growth
Health
P/E Ratio	33.96
Forward P/E Ratio	31.60
EPS	10.64
1YR Price Target	267.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	5,800
Country	USA
Website	MEDP

Medpace Holdings Inc is a clinical contract research organization. It is engaged in scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. It operates in North America, Europe, Africa, Middle East, Asia-Pacific and Latin America.

MEDP's peers: ACRS, CRL, ICLR, IQV, NEOG, QGEN, WAT, IDXX, RVTY, SYNH, LH, MTD, TWST, MYGN, SHC

*Chart delayed

Analyzing fundamentals for MEDP we got that it has strong fundamentals where Valuation is considered to be fairly valued, Profitability is stunning wealthy, Growth is exceptionally good and Health is strong. For more detailed analysis please see MEDP Fundamentals page.

Watching at MEDP technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on MEDP Technicals page.